The Global Health Body Sounds Alert Over Critical Shortage of Weight-Loss Medications
Fewer than 10% of individuals eligible to benefit from weight-loss injections like Wegovy have access to them, caution the World Health Organization as it publishes its initial recommendations on the therapies.
Considering over a billion people worldwide now obese, it is advocating for more widespread and fairer availability to GLP-1 medication.
Based on projections, in excess of 2,000,000,000 will be living with obesity by 2030 if no action is taken.
"Our new guidance acknowledges that excess weight is a long-term condition that can be treated with thorough and ongoing support," stated the agency's head Tedros Adhanom Ghebreyesus.
Significant expense, constrained manufacturing, and logistical bottlenecks are major obstacles to universal access to the injections that can aid individuals in losing considerable body mass, explains the organization.
Skinny Jab Scarcity
Even under the current best projected scenario, the supply of these medications would only suffice for approximately 100 million people – less than 10% of the global need, as stated by the health organization.
The guideline encourages governments and firms to increase access, through measures like licensing agreements.
A patent on a key compound – the core ingredient of Novo Nordisk's Wegovy – is set to lapse in several nations in 2026.
The Way Weight-Loss Jabs Operate
These medications replicate a body's own hormone to slow digestion, suppress the appetite and boost feelings of fullness so people consume fewer calories.
Patients usually start to lose weight within a few weeks of commencing the regular doses.
Research indicates people may put most of the weight back on within a year of discontinuing the drug, as their typical food cravings come back.
To be carrying excess weight elevates your chance for developing health problems, such as diabetes, cardiovascular issues, brain attack, and some cancers.
Excess weight affects people in all nations and was responsible for 3.7 million deaths worldwide in 2024, per the WHO.